Board

The Board of The Westmead Institute for Medical Research is comprised of 10 directors, led by Chair, Mr Richard Hill. It includes appointees of the three members - the University of Sydney, the NSW Government and the Westmead Medical Research Foundation.

The Board is responsible for oversight of the policies, strategic direction and management of the Institute.

Paul Bell

Paul is an independent, non-executive director and member of the Board's Human Resources and Remuneration Committee.

Experience and expertise

  • Non-Executive Director, Cochlear Ltd (2005-2014); Biota Holdings Ltd (2006-2013); Biolink Partners (2005-2009); GroPep Ltd (2002-2006).
  • Trustee, Westmead Charitable Trust (2013-Present).
  • Chair of the Westmead Institute for Medical Research Advisory Board (2003-2010) 
  • Paul’s executive career was primarily with Merck and Co Inc, including Managing Director MSD Australia Ltd (1988-1997) and President of the Asia Pacific Division (1997-2002).

Qualifications

M.A. (Hons)

Stephen Garton

Professor Stephen Garton is a non-executive director appointed by the University of Sydney.

Experience and expertise

Stephen Garton is Professor of History and Provost and Deputy Vice-Chancellor at the University of Sydney. He is the author or co-author of six books (one forthcoming) and over sixty articles and chapters. He is a Fellow of the Australian Academy of the Humanities, the Academy of Social Sciences in Australia and the Royal Australian Historical Society. In 2003 he was awarded a Commonwealth Centenary Medal for services to Australian History.

He has been a member of the Editorial Board of the Australian Dictionary of Biography (1995-) , the Australian Research Council Advisory Committee (2011-2014) , the ARC Laureate Fellowships Committee (2010-13), NSW Government Centenary of Anzac Advisory Committee (2013-), and a member of the Board of the Westmead Millennium Institute (2011-13 and now the Westmead Institute of Medical Research 2016-), Board of the United States Studies Centre (2009-), and Council of the Australian Academy of the Humanities (2006-8). He is also  an expert assessor for the National Cultural Heritage Committee and a member of the validation panel for the Draft Citizenship Test Resource Book. Recently he was a member of the Australian Council of Learned Academies committee, Securing Australia’s Future Report 13, "Reviewing  the Australian Research Training System”. 

Qualifications

BA (Macquarie), MCom, PhD (UNSW)

 

David Cook

David is a non-executive director appointed by the University of Sydney and a member of the Board's Human Resources and Remuneration Committee.

Experience and expertise

Professor David Cook is Professor of Cellular Physiology at the University of Sydney and has over 30 years experience in research on the molecular mechanisms underlying the transport of ions by epithelia. He is currently also Deputy Dean of the Faculty of Medicine at the University of Sydney and between 2010 and 2012 served as Academic Director of the Centre for Obesity, Diabetes and Cardiovascular Disease.

He was elected as a Fellow of the Australian Academy of Sciences in 2004 and has been awarded the Gottschalk medal of the Academy, the APPS Visiting Lectureship of the Physiological Society and the AuPS Annual Prize Lectureship.

He has been a member of the board of the ANZAC Foundation and joined the Board of the Institute in 2013.

Qualifications

BSc(Med), MBBS, MSc, MD, FRACP, FAA

Read more

Anthony Cunningham AO

Tony is an executive director of the Board.

Experience and expertise

Professor Tony Cunningham AO is Executive Director of the Westmead Institute for Medical Research and Director of the Centre for Virus Research. He is also Professor of Research Medicine and Sub-Dean (Research) Sydney Medical School, Westmead, the University of Sydney and Director, Australian Centre for HIV and Hepatitis Virology Research (ACH2).

He trained in infectious diseases, clinical virology and virology research at the University of Melbourne and as a postdoctoral fellow at Stanford University. His major research interests are in HIV and Herpes Simplex Virus biology and immunology, especially in relation to the development of vaccines and microbicides.

He has also published numerous original and review articles on epidemiology, antiviral therapy and vaccines for Herpes Simplex and Varicella/Zoster viruses, has participated in numerous international roundtables and often consults for global pharma on these topics.

He has published more than 280 primary refereed scientific articles and 70 invited reviews or chapters in various journals or books and has been cited more than 10,000 times.

In 2010, Tony was awarded an Officer in the Order of Australia for “service to medicine, particularly in the field of viral research and through the development and leadership of medical and biomedical research”.

Qualifications

MD, FRACP, FRCPA, FASM, FAHMS

Read more

Richard Hill

Richard is Chair of the Board, a non-executive director and an ex-officio member of the Board's Audit and Risk and Human Resources and Remuneration Committees.

Experience and expertise

Mr Richard Hill has broad experience in the medical research and development sector. He is currently Chairman of Sirtex Medical Limited and Blackwall Property Funds Limited.

He was a founding partner of Hill Young & Associates, a corporate advisory firm, and formerly held a number of senior executive positions in Hong Kong and New York with Wardley Holdings Limited, a wholly owned subsidiary of Hong Kong & Shanghai Banking Corporation (HSBC).  Richard has also served as the Chairman of Insearch, a commercial education provider (subsidiary of the University of Technology Sydney); Chairman of Calliden Group Limited; and as Non-Executive Director of Biota Pharmaceuticals, Inc.

He was admitted as an attorney in New York State (USA) and registered by the US Securities & Exchange Commission, the Ontario Securities Commission and the British Columbia Securities Commission.

Qualifications

BA, LLB (USyd) LLM (London School of Economics)

Danny O'Connor

Danny is a non-executive director appointed by the NSW Government and a member of the Board's Audit and Risk Committee.

Experience and expertise

Mr Danny O’Connor commenced his health career over 30 years ago as a community health clinician at St Vincent’s Hospital in Sydney. Other senior leadership positions have included Senior Policy Analyst with the NSW Department of Health; Director of Drug Health Services with Central Sydney Area Health Service; General Manager of the Sydney Dental Hospital; and General Manager of Concord Repatriation General Hospital. He was Chief Executive of regional Greater Western Area Health Service in NSW between 2009 and 2010 and appointed Chief Executive of the newly formed Western Sydney Local Health District in January 2011.

He is a Board Member of Western Sydney Local Health District; HealthShare NSW; WentWest; HealtheNet Program.

Qualifications

BSOCSTD (Hons) MSW (Social Policy)

Susan Young

Susan is a non-executive director and Chair of the Board's Human Resources and Remuneration Committee.

Experience and expertise

Ms Susan Young has extensive experience in business, finance, consulting and governance having retired as a Partner of Spencer Stuart at the end of 2010.  Her executive search career was preceded by a corporate career with Lend Lease Corporation where she served as President of SITEL Asia Pacific and as CEO of SITEL Australia, both joint ventures between Lend Lease and SITEL Inc. of the USA, a leading global provider of customer experience management and business process outsourcing.   She also previously served as CFO of Lend Lease Corporate Services, a subsidiary of Lend Lease and as Director of Lend Lease IT+T Investments. Susan also worked for many years in corporate and investment banking in the USA and Australia for Citigroup, Wardley Australia, First National and GATX Capital Corporation where she specialised in structured finance and cross border leasing.

Susan is currently running her own executive coaching, mentoring, leadership and executive assessment business, Young Executive Services.   She is also a non-executive director of, and serves as Chair of, ClearView Life Nominees Pty Ltd, a subsidiary of ClearView Wealth Limited, an Australia financial services company offering a comprehensive range of investment, life insurance, superannuation products and financial advice. She is also a Governor of WWF Australia, having served on its board as a non-executive director for eight years and she previously served on the board of the Australia Council of Businesswomen.

Qualifications

BA (Hons), MA, FGIA, FCIS and MAICD

Bill Ketelbey

Dr Bill Ketelbey is a non-executive director.

Experience and expertise 

Dr Bill Ketelbey is a highly experienced healthcare, pharmaceutical and biotech sector professional, with more than 30 years’ experience, including most recently as CEO and Managing Director for the ASX listed biotechnology company, Actinogen Medical (ASX:ACW). Actinogen Medical is developing innovative treatments for Alzheimer’s disease and the cognitive impairment associated with neurogenerative and metabolic diseases. Prior to joining Actinogen Medical, Dr Ketelbey was an independent consultant, focusing on the Healthcare and Pharmaceutical industries in the APAC region and held a number of senior positions at Pfizer, including Regional Vice-President of Medical Affairs at Pfizer for Australia/New Zealand, Japan, Canada and Korea, Senior Vice-President/Senior Medical Director for Pfizer Japan and Country Medical Director for Pfizer ANZ.

Dr Ketelbey has a solid track record of product development over his years in the industry leading to the successful registration and commercialisation of numerous market leading medicines across a broad range of therapeutic areas.

Qualifications

Dr Ketelbey is a medical graduate from the University of the Witwatersrand, South Africa, a Fellow of the Faculty of Pharmaceutical Physicians from the Royal College of Physicians in the UK, has an MBA from Macquarie Graduate School of Management, Australia and is a Graduate of the Australian Institute of Company Directors

David Borger

David was appointed by the Chamber in 2012 as inaugural Western Sydney Director of the Sydney Business Chamber.

The Western Sydney First program works with members to engage with decision makers and advocate for enlightened public policy that drives the region forward.

David led a campaign in support of the Western Sydney Airport at Badgerys Creek including establishing the Western Sydney Airport Alliance. He has collaborated with chief executive officers, managing partners and Vice Chancellors to support campaigns like the Powerhouse Museum to Parramatta, the Westmead and Liverpool Innovation Districts, Sydney Olympic Park, Parramatta Light Rail and West Metro.

Prior to this, he served in the NSW Labor Government as the Minister for Roads, Minister assisting the Minister for Transport and Roads, Minister for Housing, as well as Minister for Western Sydney.

As Housing Minister, David oversaw the construction of approximately 9,000 new social housing dwellings - including 6,300 through the Nation Building Economic Stimulus Plan. David has also worked as an Urban Planner and adviser to the Minister for Planning.

He was also the youngest person, at 30 years of age, to hold the office of Lord Mayor of Parramatta, where he served for three terms.

David is currently a Director of Think Planners; and serves as a non-executive director on the boards of the Sydney Festival, Evolve Housing, and the Westmead Medical Research Foundation as well as a member of the advisory board of the Southern Cross Group.